Sinopharm Group Co Ltd
HKEX:1099
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinopharm Group Co Ltd
HKEX:1099
|
CN |
|
Bukit Asam Tbk PT
IDX:PTBA
|
ID |
Multiples-Based Value
The
Multiples-Based Value for
Sinopharm Group Co Ltd (1099)
under the Base Case is
123.7
HKD.
Compared with the current market price of 21.5 HKD, the stock appears
Undervalued by 83%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Sinopharm Group Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.1B HKD | 0.1 | 8.4 | 0.8 | 1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
107.2B USD | 0.3 | 24.7 | 17.4 | 19.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.2B USD | 0.2 | 38.9 | 13.8 | 17.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.3B USD | 0.2 | 38.3 | 13.6 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD | 0.2 | 30.5 | 14.7 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.1B AUD | 2.7 | 34.1 | 25.3 | 25.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.6B CNY | 1.5 | 17.2 | 13.3 | 13.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 22 | 10.8 | 15.3 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.7B USD | 0.9 | 48.7 | 32.1 | 32.1 |